000			01759 a2200469 4500
005			20250516221434.0
264		0	_c20151002
008			201510s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0100562 _2doi
040			_aNLM _beng _cNLM
100	1		_aZaafar, Dalia K
245	0	0	_aRole of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation. _h[electronic resource]
260			_bPloS one _c2014
300			_ae100562 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a1,2-Dimethylhydrazine _xtoxicity
650	0	4	_aAnimals
650	0	4	_aAntigens, CD34 _xmetabolism
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aColon _xdrug effects
650	0	4	_aColonic Neoplasms _xchemically induced
650	0	4	_aDiabetes Mellitus, Experimental _xdrug therapy
650	0	4	_aDiet, High-Fat
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aInsulin-Like Growth Factor I _xanalysis
650	0	4	_aMale
650	0	4	_aMetformin _xpharmacology
650	0	4	_aMice
650	0	4	_aNeovascularization, Pathologic _xmetabolism
650	0	4	_aOrganoplatinum Compounds _xtherapeutic use
650	0	4	_aOxaliplatin
650	0	4	_aReceptor, IGF Type 1 _xmetabolism
650	0	4	_aSurvival Rate
650	0	4	_aVascular Endothelial Growth Factor A _xblood
700	1		_aZaitone, Sawsan A
700	1		_aMoustafa, Yasser M
773	0		_tPloS one _gvol. 9 _gno. 6 _gp. e100562
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0100562 _zAvailable from publisher's website
999			_c23959576 _d23959576